World's Best Scientists 2026 revealed!
Current Topics in Medicinal Chemistry
H-index 21

Current Topics in Medicinal Chemistry

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 580 55 77 13
Medicine 2294 16 26 11

Additional Metrics

Number of Best Scientists*: 154
Documents by Best Scientists*: 209
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 139
SCIMAGO SJR: 0.61
Impact Factor: 3.3

Overview

Top Research Topics at Current Topics in Medicinal Chemistry?

The journal mostly deals with topics like Pharmacology, Drug discovery, Biochemistry, Computational biology and Drug. Issues in Pharmacology were discussed, taking into consideration concepts from other disciplines like Receptor and In vivo. Enzyme and Structure–activity relationship are some of the study areas of Biochemistry discussed.

The journal investigates Computational biology research which frequently intersects with Bioinformatics. The in-depth study on Bioinformatics also explores topics in the intersecting field of Disease.

  • Pharmacology (18.87%)
  • Drug discovery (13.72%)
  • Biochemistry (12.79%)

What are the most cited papers published in the journal?

  • Toxic Metals and Oxidative Stress Part I: Mechanisms Involved in Me-tal induced Oxidative Damage (1381 citations)
  • Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. (808 citations)
  • Subunit composition, distribution and function of GABA(A) receptor subtypes. (766 citations)

Research areas of the most cited articles at Current Topics in Medicinal Chemistry:

The most cited papers generally zeroe in on subjects such as Pharmacology, Biochemistry, Drug discovery, Receptor and Cell biology. The most cited publications feature studies on Pharmacology, including topics such as Drug. The Drug discovery study tackled in the journal papers is a key component of adjacent topics in the area of Computational biology.

What topics the last edition of the journal is best known for?

  • Enzyme
  • Gene
  • Internal medicine

The previous edition focused in particular on these issues:

The scientific interests tackled in the journal are Drug, Computational biology, Cancer, Cancer research and Drug discovery. The Drug research discussed is included in the broader subject of Pharmacology. Many of the studies tackled connect Computational biology with a similar field of study like Quantitative structure–activity relationship.

The work on Cancer addressed in Current Topics in Medicinal Chemistry expands to the thematically related Bioinformatics. Some problems in Cancer research that were presented in it overlapped with concepts under Cancer cell and Drug resistance. Current Topics in Medicinal Chemistry focused on works that combine different research areas such as Drug discovery and Context (language use).

The most cited articles from the last journal are:

  • A Review on Natural Sources Derived Protein Nanoparticles as Anticancer Agents. (11 citations)
  • The effect of recombinant human interferon alpha nasal drops to prevent COVID-19 pneumonia for medical staff in an epidemic area. (10 citations)
  • Interaction of Platinum-based Drugs with Proteins: An Overview of Representative Crystallographic Studies. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Current Topics in Medicinal Chemistry (based on the number of publications) are:

  • Marcus Tullius Scotti (30 papers) published 3 papers at the last edition, 3 less than at the previous edition,
  • Luciana Scotti (26 papers) published 2 papers at the last edition, 4 less than at the previous edition,
  • Craig W. Lindsley (23 papers) absent at the last edition,
  • Anuraj Nayarisseri (23 papers) published 1 paper at the last edition, 5 less than at the previous edition,
  • Eduardo Sobarzo-Sánchez (22 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Topics in Medicinal Chemistry (based on the number of publications) are:

  • University of Santiago de Compostela (56 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Chinese Academy of Sciences (40 papers) published 5 papers at the last edition, 2 more than at the previous edition,
  • University of São Paulo (39 papers) published 4 papers at the last edition, 3 less than at the previous edition,
  • Merck & Co. (38 papers) absent at the last edition,
  • Federal University of Paraíba (35 papers) published 3 papers at the last edition, 5 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.28% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 11.17% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.06% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.61% of all publications and 68.16% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Gut Dysbiosis Dysregulates Central and Systemic Homeostasis via Suboptimal Mitochondrial Function: Assessment, Treatment and Classification Implications

    George Anderson;Michael Maes

    (2020)
    80 Citations
  • Nanotechnology, A Tool for Diagnostics and Treatment of Cancer.

    Abdul Nasir;Amir Khan;Jiayi Li;Muhammad Naeem

    (2021)
    49 Citations
  • Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials.

    Nicola Relitti;Akella P. Saraswati;Stefano Federico;Tuhina Khan

    (2020)
    43 Citations
  • Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review.

    Rinky Raghuvanshi;Sandip B. Bharate

    (2020)
    33 Citations
  • Plant-food-derived bioactives in managing hypertension: From current findings to upcoming effective pharmacotherapies.

    (2023)
    33 Citations
  • Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia.

    Hussein Kadhem Al-Hakeim;Abbas F. Almulla;Arafat Hussein Al-Dujaili;Michael Maes

    (2020)
    29 Citations
  • An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine.

    Domenico De Berardis;Carmine Tomasetti;Maurizio Pompili;Gianluca Serafini

    (2020)
    28 Citations
  • Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward

    Danny Feijtel;Marion de Jong;Julie Nonnekens

    (2020)
    28 Citations
  • Agathisflavone, a Biflavonoid from Anacardium occidentale L., Inhibits Influenza Virus Neuraminidase.

    Caroline S de Freitas;Marco E N Rocha;Carolina Q Sacramento;Andressa Marttorelli

    (2020)
    24 Citations
  • Salivary mir-27b Expression in Oral Lichen Planus Patients: A Series of Cases and a Narrative Review of Literature.

    Dario Di Stasio;Laura Mosca;Alberta Lucchese;Donatella Delle Cave

    (2020)
    23 Citations

Related Online Degrees & Career Pathways

Exploring alternative career paths in healthcare can complement your medical education or offer viable options if you’re seeking different roles. For those interested in advanced nursing roles, understanding the pmhnp salary across states provides insight into lucrative opportunities as psychiatric nurse practitioners.

If you’re aiming to accelerate your nursing career, consider programs highlighted for their efficiency, such as fast track nurse practitioner programs. These options allow you to enter the workforce sooner without compromising on quality education.

Many nurses take advantage of flexible and accelerated degree options like an rn to bsn in 6 months, which quickly boosts qualifications and opens doors to advanced positions. Similarly, bridge programs such as adn to fnp enable registered nurses to transition seamlessly into family nurse practitioner roles.

Understanding these pathways helps you make informed decisions about your professional journey, enhancing your credentials and broadening your career prospects in health care.

Best Scientists Contributing to This Journal

Recently Published Articles